Literature DB >> 7382554

Spinal cord compression: with special reference to metastatic epidural tumors.

M Rodriguez, R P Dinapoli.   

Abstract

Compression of the spinal cord or cauda equina is an increasingly important problem in cancer patients. The most common primary tumors are carcinoma of the breast in women and carcinoma of the lung in men. Metastases invade the epidural space by extension from involved vertebrae, by growth through intevertebral foramina, and by hematogenous dissemination. Pain is the usual initial symptom, followed by progressive sensory, motor, and sphincteric dysfunction. Appropriate x-ray films of the spine are positive in most patients, and complete myelographic examination to delineate the exact location and extent of the compression is essential. Patients generally require emergency management; results of treatment depend primarily on the neurologic status at the time of diagnosis. Corticosteroids should be administered in an effort to reduce compressive edema. Decompressive laminectomy followed by radiation therapy is indicated for patients with compression of unknown cause, relapse during or after radiation therapy, or certain radioresistant tumors. Primary radiation therapy is indicated for patients with lymphoma and some patients with carcinoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7382554

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  11 in total

1.  Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases.

Authors:  D E Weissman; N A Janjan; B Erickson; F J Wilson; M Greenberg; P S Ritch; T Anderson; R M Hansen; C R Chitambar; C A Lawton
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

Review 2.  Back pain and epidural spinal cord compression.

Authors:  D W Bates; J B Reuler
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

Review 3.  Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.

Authors:  Ali Batouli; John Braun; Kamal Singh; Ali Gholamrezanezhad; Bethany U Casagranda; Abass Alavi
Journal:  J Neurooncol       Date:  2018-02-26       Impact factor: 4.130

4.  Spine radiosurgery for spinal cord compression: the radiation oncologist's perspective.

Authors:  William F Regine; Samuel Ryu; Eric L Chang
Journal:  J Radiosurg SBRT       Date:  2011

5.  Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC).

Authors:  J A Martenson; R G Evans; M R Lie; D M Ilstrup; R P Dinapoli; M J Ebersold; J D Earle
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  (18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy.

Authors:  Kenzo Uchida; Hideaki Nakajima; Tsuyoshi Miyazaki; Tatsuro Tsuchida; Takayuki Hirai; Daisuke Sugita; Shuji Watanabe; Naoto Takeura; Ai Yoshida; Hidehiko Okazawa; Hisatoshi Baba
Journal:  Asian Spine J       Date:  2013-05-22

7.  Accuracy of prognostic scores in decision making and predicting outcomes in metastatic spine disease.

Authors:  H Majeed; S Kumar; R Bommireddy; Z Klezl; D Calthorpe
Journal:  Ann R Coll Surg Engl       Date:  2012-01       Impact factor: 1.891

8.  Metastatic human breast cancer to the spine produces mechanical hyperalgesia and gait deficits in rodents.

Authors:  Rachel Sarabia-Estrada; Alejandro Ruiz-Valls; Hugo Guerrero-Cazares; Ana M Ampuero; Ismael Jimenez-Estrada; Samantha De Silva; Lydia J Bernhardt; Courtney Rory Goodwin; Ali Karim Ahmed; Yuxin Li; Neil A Phillips; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa; Daniel M Sciubba
Journal:  Spine J       Date:  2017-04-13       Impact factor: 4.166

9.  Imaging of spinal metastatic disease.

Authors:  Lubdha M Shah; Karen L Salzman
Journal:  Int J Surg Oncol       Date:  2011-11-03

10.  Magnetic resonance imaging of spinal metastases.

Authors:  D J Chadwick; D A Gillatt; A Mukerjee; J B Penry; J C Gingell
Journal:  J R Soc Med       Date:  1991-04       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.